Pharmacists in Lapeer, Michigan


30 Pharmacists found in Lapeer
female pharmacist

Dr. Kimberly Ann Proffer, PHARMD, RPH


Pharmacist
15555 Demill Rd, Lapeer, MI 48446
810-667-8133    

female pharmacist

Kris Cavanaugh


Pharmacist
571 S Main St, Lapeer, MI 48446
810-538-0014    

female pharmacist

Linda Wood, RPH


Pharmacist
571 S Main St, Lapeer, MI 48446
810-538-0014     810-538-0020



female pharmacist

Mariam Farhood


Pharmacist
1555 Demille Rd, Lapeer, MI 48446
810-667-8110    

male pharmacist

Dr. Nickolas John Kipreos, RPH


Pharmacist
555 E Genesee St, Lapeer, MI 48446
810-664-8360    

female pharmacist

Sally Riyadh Konja


Pharmacist
555 E Genesee St, Lapeer, MI 48446
810-664-8360    

female pharmacist

Saral Nitin Patel, PHARMD


Pharmacist
1022 W Genesee St, Lapeer, MI 48446
714-906-4757    

male pharmacist

Sean Loftus, PHARM.D.


Pharmacist
1570 Suncrest Dr Ste 300, Lapeer, MI 48446
810-245-4950     810-515-7558

female pharmacist

Sikha Patel


Pharmacist
555 E Genesee St, Lapeer, MI 48446
810-664-8360    

female pharmacist

Susan Kay Winslow


Pharmacist
555 E Genesee St, Lapeer, MI 48446
810-664-8360     810-664-8705

male pharmacist

Susmitkumar Patel


Pharmacist
944 Baldwin Rd Ste B, Lapeer, MI 48446
810-245-9600     810-969-4013

female pharmacist

Theresa Crisp, RPH


Pharmacist
1177 Kensington Ct, Lapeer, MI 48446
810-664-7593    

male pharmacist

Tyler Joshua Bradley, PHARM.D.


Pharmacist
1022 W Genesee St, Lapeer, MI 48446
810-664-4578    

female pharmacist

Valerie Pitsch, RPH


Pharmacist
1254 N Main St, Lapeer, MI 48446
810-664-1932    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.